Sigurdur O. Olafsson

Companies

• Keenova Therapeutics plcBoard member Jun 30, 2022 to now¹
• Keenova Therapeutics plcChief executive officer Jun 30, 2022 to now¹
• Keenova Therapeutics plcPresident Jun 30, 2022 to Sep 25, 2025¹
• Allergan plcBoard member Oct 3, 2013 to Nov 13, 2013²
• Allergan plcPRES.-ACTAVIS PHARMA Oct 3, 2013 to Nov 13, 2013²
• ActavisEXEC VP, GLOBAL GENERICS Sep 2, 2010 to Oct 2, 2013³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKeenova Therapeutics plc31,718 shares⁴Jan 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 1, 2026Shares withheld for tax 16,939 shares of Keenova Therapeutics plc⁴
• Jan 1, 2026Exercised options 32,878 shares of Keenova Therapeutics plc⁴
• Jan 1, 2025Shares withheld for tax 11,580 shares of Keenova Therapeutics plc⁵
• Jan 1, 2025Shares withheld for tax 11,576 shares of Keenova Therapeutics plc⁶
• Jan 1, 2025Exercised options 27,355 shares of Keenova Therapeutics plc⁵
• Nov 14, 2023Returned to company 189,863 shares of Keenova Therapeutics plc⁷
• Jun 23, 2023Shares withheld for tax 38,409 shares at $1.31 of Keenova Therapeutics plc⁸
• Mar 13, 2023Bought 3,000 shares at $8.37 of Keenova Therapeutics plc⁹
• Dec 14, 2022Granted 225,272 shares of Keenova Therapeutics plc¹⁰